Colonic Drug Targeting

References

• Adkin D. A., Davis S. S., Sparow R. A., Wilding I. R. Colonic transit of different sized tablets in healthy subjects. J. Controlled Rel 1993; 23: 147–153
   Web of Science ®Google Scholar
• Alwood M. C., Archer D. B., Ring S. G. Delayed release formulations. Eur. Pat. Appl. 0343993A1, 1989
   Google Scholar
• Ashford M., Fell J. T., Attwood D., Woodhead P. J. An in vitro investigation into the suitability of pH-dependent polymer for colonic targeting. Int. J. Pharm 1992; 94: 241–245
   Google Scholar
• Ashford M., Fell J. T., Attwood D., Sharma H., Woodhead P. J. An in vivo investigation into the suitability of pH-dependent polymers for colon targeting. Int. J. Pharm 1993a; 95: 193–199
   Web of Science ®Google Scholar
• Ashford M., Fell J. J., Attwood D., Sharma H. L., Woodhead P. J. An evaluation of pectin as carrier for drug targeting to the colon. J. Controlled Rel 1993b; 26: 213–220
   Web of Science ®Google Scholar
• Ashford M., Fell J., Attwood D., Sharma H., Woodhead P. Studies on pectin formulations for colonic drug delivery. J. Controlled Rel 1994; 30: 225–232
   Web of Science ®Google Scholar
• Azad Khan A. K., Piris J., Truelove S. C. An experiment to determine the active therapeutic moiety of sulphasalazine. The Lancet 1977; 2: 895–895
   PubMedGoogle Scholar
• Bauer K. H., Kesselhut J. F. Novel pharmaceutical excipients for colon targeting. S. T. P. Pharma Sci 1995; 5: 54–59
   Web of Science ®Google Scholar
• Binder H. J., Foster E. S., Budinger M. E., Hayslett J. P. Mechanism of electroneural sodium chloride absorption in distal colon of the rat. Gastroenterology 1987; 93: 449–455
   PubMed Web of Science ®Google Scholar
• Binns J. S., Stevens H. N. E., Bakhshaee M., Wilson C. G. Colon targeted release using the Pulsincap delivery system. Proc. Intern. Symp. Control. Rel. Bioact. Mater 1994; 21: 260–261
   Google Scholar
• Bown R. L., Gibson J. A., Sladen G. E., Hicks B., Dawson A. M. Effects of lactulose and other laxatives on ileal and colonic pH as measured by a radiotelemetry device. Gut 1974; 15: 999–1004
   PubMed Web of Science ®Google Scholar
• Brondsted H., Kopecek J. Hydrogels for site-specific oral drug delivery: Synthesis and characterization. Biomater-ials 1991; 12: 584–592
   PubMed Web of Science ®Google Scholar
• Brondsted H., Kopecek J. Hydrogels for site-specific drug delivery to the colon: In vitro and in vivo degradation. Pharm. Res 1992; 9: 1540–1545
   PubMed Web of Science ®Google Scholar
• Brondsted H., Hovgaard I., Simonsen I. Dextran hydrogels for colon-specific drug delivery IV. Comparative release study of hydrocortisone and prednisolone phosphate. STP Pharma Sciences 1995; 5: 65–69
   Google Scholar
• Brown J. P., McGarraugh G. V., Parkinson T. M., Wingerd R. E., Jr., Oderndonck A. B. A polymeric drug for treatment of inflammatory bowel disease. J. Med. Chem 1983; 26: 1300–1307
   PubMed Web of Science ®Google Scholar
• Cann P. A., Read N. W., Brown C., Hobson N., Holdsworth. Irritable bowel syndrome: Relationship of disorders in the transit of a single solid meal to symptom patterns. Gut 1983; 24: 405–411
   PubMed Web of Science ®Google Scholar
• Chan R. P., Pope D. J., Gilbert A. P., Sacra P. J., Baron J. H., Lennard-Jones J. E. Studies of two novel sulphasalazine analogs, ipsalazide and balsalazide. Dig. Dis. Sci 1983; 28: 609–615
   PubMed Web of Science ®Google Scholar
• Cheng C. L., Gehrke St. H., Ritschel W. A. Development of an azopolymer based colonic release capsule for delivering proteins/macromolecules. Meth. Find. Exp. Clin. Pharmacol 1994; 16: 271–278
   PubMed Web of Science ®Google Scholar
• Connel A. M. Motor action of the large bowel. Handbook of Physiology, C. F. Coda, W. Heidel. American Physiology Society, Washington, D. C. 1968; Vol. IV: 66–92, Sect 6
   Google Scholar
• Cooper M. D., Perey D. Y., McKnealiky M. F., Gabrielsa A. E., Sutherland D. E. R., Good R. A. A mammalian equivalent of the avian Bursa of fabricus. Lancet 1966; 1: 1388–1391
   PubMed Web of Science ®Google Scholar
• Davis S. S. Assessment of gastrointestinal transit and drug absorption. Novel Drug Delivery and its Therapeutic Application, L. F. Prescott, S. W. Nimmo. Wiley, Chichester 1989; 89–101
   Google Scholar
• Davis S. S., Hardy J. G., Fara J. W. Transit of pharmaceutical dosage forms through the small intestine. Gut 1986; 27: 886–892
   PubMed Web of Science ®Google Scholar
• Davis S. S., Hardy J. G., Newman S. P., Wilding I. R. Gamma scintigraphy in the evaluation of pharmaceutical dosage forms. Eur. J. Nucl. Med 1992; 19: 971–986
   PubMedGoogle Scholar
• Edlund C., Lidbeck A., Kager L., Nord C. E. Comparative effects of enoxacin and norfloxacin on human colonic microflora. Antimicrob. Agents Chemother 1987; 31: 1846–1848
   PubMed Web of Science ®Google Scholar
• Enck P., Merlin V., Erckenbrecht J. F., Wienbeck M. Stress effects on gastrointestinal transit in the rat. Gut 1989; 30: 455–459
   PubMed Web of Science ®Google Scholar
• Evans D. F., Pye G., Bramley R., Clark A. G., Dyson T. J., Hardcastle J. D. Measurement of gastrointestinal pH profiles in normal ambulant human subjects. Gut 1988; 29: 1035–1041
   PubMed Web of Science ®Google Scholar
• Fara J. W. Colonic drug absorption and metabolism. Novel Drug Delivery and Therapeutics, L. F. Prescott, W. S. Nimmo. Wiley, Chichester 1989; 103–112
   Google Scholar
• Fix J. A. Absorption enhancing agents for gastrointestinal system. J. Controlled Rel 1987; 6: 151–162
   Google Scholar
• Fix J. A. Strategies for delivery peptides utilizing absorption-enhancing agents. J. Pharm. Sci 1996; 85: 1282–1285
   PubMed Web of Science ®Google Scholar
• Friend D. R., Chang G. W. A colon-specific drug delivery system based on drug glycosides and glycosidases of colonic bacteria. J. Med. Chem 1984; 27: 261–266
   PubMed Web of Science ®Google Scholar
• Friend D. R., Chang G. W. Drug glycosides: Potential prodrugs for colon-specific drug delivery. J. Med. Chem 1985; 28: 51–57
   PubMed Web of Science ®Google Scholar
• Friend D. R., Tozer T. N. Drug glycosides in oral colon-specific drug delivery. J. Controlled Rel 1992; 19: 109–120
   Web of Science ®Google Scholar
• Friend D. R. Glycoside prodrugs: novel pharmacotherapy for colonic diseases. S. T. P. Pharma Sci 1995; 5: 70–76
   Web of Science ®Google Scholar
• Gazzaniga A., Bussetti C., Moro L., Sangali M. E., Giordano F. Time dependent oral delivery systems for colon targeting. S. T. P. Pharma. Sci 1995; 5: 83–88
   Web of Science ®Google Scholar
• Gazzaniga A., Iamartino P., Maffione G., Sangalli M. E. Oral delayed release system for colonic specific delivery. Int. J. Pharm 1994; 108: 77–83
   Web of Science ®Google Scholar
• Ghandehari H., Kopeckova P., Kopecek J. In vitro biodegradation of pH-sensitive hydrogels containing aromatic azo bonds. Biomaterials 1997; 18: 861–872
   PubMed Web of Science ®Google Scholar
• Gibson S. A. W., McFarlan C., Hay S., Macfarlane G. T. Significance of microflora in proteolysis in the colon. Appl. Environm. Microbiol 1989; 55: 679–683
   PubMed Web of Science ®Google Scholar
• Gingell J. C., Davies M. W., Shields R. Effect of synthetic gastrin-like pentapeptide upon the intestinal transport of sodium, potassium and water. Gut 1968; 9: 111–115
   PubMed Web of Science ®Google Scholar
• Gleiter C. H., Antonin K. H., Bieck P., Godbillon J., Schonleber W., Malchow H. Colonoscopy in the investigation of drug absorption in healthy volunteers. Gastrointest. Endosc 1985; 31: 71–73
   PubMed Web of Science ®Google Scholar
• Goldstein D. A., Tan Y. K., Soldin S. J. Pharmacokinetics and absolute bioavailability of salbutamol in healthy adult volunteers. Eur. J. Clin. Pharmacol 1987; 32: 631–634
   PubMed Web of Science ®Google Scholar
• Gorbach S. L. Intestinal microflora. Gastroenterology 1971; 60: 1110–1129
   PubMed Web of Science ®Google Scholar
• Gruber P., Longer M. A., Robinson J. R. Some biological issues in oral, controlled drug delivery. Adv. Drug Del. Rev 1987; 1: 1–18
   Google Scholar
• Haeberlin B., Friend D. R. Anatomy and physiology of the gastrointestinal tract. Oral Colon-Specific Drug Delivery, D. R. Friend. CRC Press, Boca Raton 1992; 1–43
   Google Scholar
• Hagikara P. F., Griffin W. O. J. Physiology of the colon and the rectum. Surg. Clin. North. Am 1977; 52: 797–805
   Google Scholar
• Harboe E., Larsen C., Johansen M., Olesen H. P. Macromolecular prodrugs XV. Colon targeted delivery bioavailability of naproxen from orally administered dex-tran-naproxen prodrugs varying in molecular size in the pig. Pharm. Res 1989; 6: 919–923
   PubMed Web of Science ®Google Scholar
• Hardy J. G. Colonic transit and drug delivery. Drug Delivery to the Gastrointestinal Tract, J. G. Hardy, S. S. Davis, C. G. Wilson. Ellis Horwood, Chichester 1989; 75–81
   Google Scholar
• Hardy J. G., Healy J. N. C., Reynolds J. R. Evaluation of an enteric coated delayed release 5-aminosalicylic acid tablet in patients with inflammatory bowel disease. Alimentary Pharmacol. Therap 1987; 1: 273–280
   PubMedGoogle Scholar
• Hardy J. G., Davis S. S., Khosla R., Robertson C. S. Gastrointestinal transit of small tablets in patients with ulcerative colitis. Int. J. Pharm 1988; 48: 79–82
   Web of Science ®Google Scholar
• Hardy J. G., Wilson C. G., Wood E. Drug delivery to the proximal colon. J. Pharm. Pharmacol 1985; 37: 874–877
   PubMed Web of Science ®Google Scholar
• Hawker P. C., Mashier K. E., Turnberg L. A. Mechanism of transport of sodium chloride and potassium in the human colon. Gastroenterology 1978; 74: 1241–1247
   PubMedGoogle Scholar
• Hill M. J., Drasar B. S. The normal colonic bacterial flora. Gut 1975; 16: 318–323
   PubMed Web of Science ®Google Scholar
• Hirayama F., Minami K., Uekama K. In vitro evaluation of biphenyl acetic acid-β-cyclodextrin conjugates as colon targeting prodrugs: drug release behaviour in rat biological media. J. Pharm. Pharmacol 1996; 48: 27–31
   PubMed Web of Science ®Google Scholar
• Hirsch S., Binder V., Kolter K., Kesselhut J. F., Bauer K. H. Lauroyldextran as a coating material for site-specific drug delivery to the colon: in vitro dissolution of coated tablets. Proc. Int. Symp. Control. Rel. Bioact. Mater 1997; 24: 379–380
   Google Scholar
• Hovgaard L., Bronsted H. Dextran hydrogels for colon-specific drug delivery. J. Controlled Rel 1995; 36: 159–166
   Web of Science ®Google Scholar
• Ikesue K., Kopeckova P., Kopecek J. Degradation of proteins by enzymes of the gastrointestinal tract. Proc. Intern. Symp. Control. Rel. Bioact. Mater 1991; 18: 580–581
   Google Scholar
• Jay M., Beihn R. M., Digenis G. A., Deland F. H., Caldwell L., Mlodozeniec A. R. Disposition of radiolabeled suppositories in humans. J. Pharm. Pharmacol 1985; 37: 266–268
   PubMed Web of Science ®Google Scholar
• Kalala W., Kinget R., Van den Mooter G., Samyn C. Colonic drug targeting: in vitro release of ibuprofen from capsules coated with poly(ether-ester) azo polymers. Int. J. Pharm 1996; 139: 187–195
   Web of Science ®Google Scholar
• Khosla R., Davis S. S. Gastric emptying and small and large bowel transit of non-disintegrating tablets in fasted subjects. Int. J. Pharm 1989; 52: 1–10
   Web of Science ®Google Scholar
• Kim J. S., Oberle R. L., Krummel D. A., Dressman J. B., Fleisher D. Absorption of ACE inhibitors from small intestine and colon. J. Pharm. Sci 1994; 83: 1350–1356
   PubMed Web of Science ®Google Scholar
• Kimura Y., Makita Y., Kumagai T., Yamane H., Kitao T., Sasatani H., Kim S. I. Degradation of azo containing polyurethane by the action of intestinal microflora. Polymer 1992; 33: 5294–5299
   Web of Science ®Google Scholar
• Kopecek J., Kopeckova P., Brondsted H., Rathi R., Rihova B., Yeh P. Y., Ikesue K. Polymers for colon-specific drug delivery. J. Controlled Rel 1992; 19: 121–130
   Web of Science ®Google Scholar
• Kopeckova P., Kopecek J. Release of 5-aminosalicylic acid from bioadhesive N-(2-hydroxypropyl)metha-crylamide copolymers by azoreductases in vitro. Makromol. Chem 1990; 191: 2037–2045
   Web of Science ®Google Scholar
• Kopeckova P., Rathi R., Takada S., Rihova B., Berenson M. M., Kopecek J. Bioadhesive N-(2-hydroxy-propyl)methacrylamide copolymers for colon-specific drug delivery. J. Controlled Rel 1994; 28: 211–222
   Web of Science ®Google Scholar
• Langguth P., Breves G., Stokli A., Merkle H. P., Wolffram S. Colonic absorption and bioavailability of the pentapeptide metkephamid in the rat. Pharm. Res 1994; 11: 1640–1645
   PubMed Web of Science ®Google Scholar
• Lee V. H. L. Changing needs in drug delivery in the era of peptide and protein drugs. Peptide and Protein Drug Delivery, V. H. L. Lee. Marcel Dekker, New York 1991; 1–56
   Google Scholar
• Lee V. H. L., Doddo-Kashi S., Grasss G. M., Rubas W. Oral route of peptide and protein drug delivery. Peptide and Protein Drug Delivery, V. H. L. Lee. Marcel Dekker, New York 1991; 691–738
   Google Scholar
• Lee V. H. L. Oral route of peptide and protein drug delivery. BioPHARM 1992; 5: 39–50
   Google Scholar
• Lehmann K. Magensaftresistente und retardierende Arzneimittelüberzuge aus wässrigen Acrylharzdispersionen. Acta Pharm. Techn 1975; 21: 255–260
   Google Scholar
• Lehmann K. O. R., Dreher K. D. Methacrylate-galactomannan coating for colon-specific drug delivery. Proceed. Intern. Symp. Control. Rel. Bioact. Mater 1991; 18: 331–332
   Google Scholar
• Leopold C. S., Friend D. R. Poly (L-aspartic acid) as drug carrier for colon-specific drug delivery. An in vitro assesment. Proc. Intern. Symp. Control. Rel. Bioact. Mater 1994; 21: 258–259
   Web of Science ®Google Scholar
• Lindsey J. T., Smith J. W., McCluggage S. G. J., Nicholas R. L. Effects of commonly used bowel preparations on the large bowel mucosa-associated and luminal microflora in the rat model. Dis. Col. Rectum 1990; 33: 554–560
   PubMed Web of Science ®Google Scholar
• Macfarlane G. T., Cummings J. H., Allison C. Protein degradation by human intestinal bacteria. J. Gen. Biol 1986; 132: 1647–1656
   Google Scholar
• Macfarlane G. T., Allison C., Gibson S. A. W., Cummings J. H. Contribution of the microflora to proteolysis in the human large intestine. J. Appl. Bacteriol 1988; 64: 37–46
   PubMedGoogle Scholar
• Macfarlane G. T., Hay S., Gibson G. R. Influence of mucin on glycosidase, protease and arylamidase activities of human gut bacteria grown in a 3-stage continuous culture system. J. Appl. Bacteriol 1989; 66: 407–417
   PubMedGoogle Scholar
• Macfarlane G. T., Gibson G. R., Beatty J. H., Cummings J. H. Estimation of short chain fatty acid production from protein by human intestinal bacteria based on branched-chain fatty acid measurements. FEMS Microbiol. Ecol 1992; 101: 81–88
   Web of Science ®Google Scholar
• Mackay M., Tomlinson E. Colonic delivery of therapeutic peptides and proteins. Colonic Absorption and Metabolism, P. R. Biek. Marcel Dekker, New York 1993; 159–176
   Google Scholar
• Macleod A. D., Tozer T. N. Kinetic perspectives in colonic drug delivery. Oral Colon-Specific Drug Delivery, DR. Friend. CRC Press, Boca Raton 1992; 85–114
   Google Scholar
• Macleod A. D., Tolentino L., Tozer T. N. Glucocorticoid dextran conjugates as potential prodrugs for colon-specific delivery: Steady state pharmacokinetics in the rats. Biopharm. Drug Disp 1994; 15: 151–161
   PubMed Web of Science ®Google Scholar
• MacNeil M. E., Stevens H. N. E. Patent WO. 90/09168, 1990
   Google Scholar
• Madara J. L., Dharmsathaphorn K. Occluding junction structure-function relationships in cultured epithelial monolayer. J. Cell Biol 1985; 101: 2124–2133
   PubMed Web of Science ®Google Scholar
• Malagelada J. R., Robertson J. S., Brown M. L., Remington M., Duenes J. A., Thomforde G. M., Carryer P. W. Intestinal transit of solid and liquid components of a meal in health. Gastroenterology 1984; 87: 1255–1263
   PubMed Web of Science ®Google Scholar
• Meldrum S. J., Watson B. W., Riddle H. C., Bown R. L., Sladen G. E. pH profile of gut as measured by radiotelemetry capsule. Br. Med. J 1972; 2: 104–106
   PubMed Web of Science ®Google Scholar
• Meschan I. Small intestine, colon and biliary tract. An Atlas of Basic Anatomy to Radiology, I. Meschan. W. B. Saunders Co., Philadelphia 1975; 843–925
   Google Scholar
• Milojevic S., Newton J. M., Cummings J. H., Gibson G. R., Botham R. L., Ring S. G., Stockham M., Allwood M. C. Amylose as a coating for drug delivery to the colon: preparation and in vitro evaluation using 5-aminosalicylic acid pellets. J. Controlled Rel 1996; 38: 75–84
   Web of Science ®Google Scholar
• Misiewics J. J. Colonic motility. Gut 1975; 16: 311–314
   PubMed Web of Science ®Google Scholar
• Molly K., Vande Woestyne M., Verstraete W. Development of a 5-step multi chamber reactor as a simulation of the human intestinal microbial ecosystem. Appl. Microbiol. Biotechnol 1993; 39: 254–258
   PubMed Web of Science ®Google Scholar
• Moore W. E. C., Holdeman L. V. Discussion of current bacteriologic investigations of the relationship between intestinal flora, diet and colon cancer. Cancer Res 1975; 35: 3418–3420
   Web of Science ®Google Scholar
• Mrsny R. J. The colon as a site for drug delivery. J. Controlled Rel 1992; 22: 15–34
   Web of Science ®Google Scholar
• Munjeri O., Collet J. H., Fell J. T. Hydrogel beads based on amidated pectins for colon-specific drug delivery: the role of chitosan in modifying drug release. J. Controlled Rel 1997; 46: 273–278
   Web of Science ®Google Scholar
• Murakami M., Yoshikawa H., Takada K., Muranishi S. Effect of oleic acid vesicles on intestinal absorption of carboxyfluorescein in rats. Pharm. Res 1986; 3: 35–40
   PubMed Web of Science ®Google Scholar
• Muranishi S. Potentials and limitations of absorption enhancers. Proceed. Int. FIP Sat. Symp.. 1987; L18
   Google Scholar
• Muranishi S. Absorption enhancers. Crit. Rev. Ther. Drug Car. Sys 1990; 7: 1–33
   PubMed Web of Science ®Google Scholar
• Muranishi S., Muranishi N., Sezaki K. Improvement of absolute bioavailability of normally poorly absorbed drug: Inducement of intestinal absorption of streptomycin and gentamycin by lipid–bile salt mixed micelles in rat and rabbit. Int. J. Pharm 1979; 2: 101–109
   Google Scholar
• Niibuchi J. J., Aramaki Y., Tchusiya S. Binding of antibiotics to rat intestinal mucin. Int. J. Pharm 1986; 30: 181–187
   Google Scholar
• Niwa K., Takaya T., Morimoto T., Takada K. Preparation and evaluation of a time-controlled release capsule made of ethylcellulose for colon delivery of drugs. J. Drug Target 1995; 3: 83–89
   PubMed Web of Science ®Google Scholar
• Nord C. E., Heimdahl A. Impact of orally administered antimicrobial agents on human oropharyngeal and colonic microflora. J. Antimicrob. Chemother 1986; 18(Suppl. C)159–164
   PubMedGoogle Scholar
• Ovesen L., Bendsten F., Tage-Jensen K., Pedersen N. T., Gram B. R., Rune S. J. Intraluminal pH in the stomach, duodenum and proximal jejenum in normal subjects and patients with exocrine pancreatic insufficiency. Gastroenterology 1986; 90: 258–262
   Google Scholar
• Peeters R. Studie over de ontwikkeling van een colon-specifieke artsenijvorm. Doctoral Thesis, K. U. Leuven. 1990
   Google Scholar
• Peeters R., Kinget R. Film-forming polymers for colonic drug delivery. I. Synthesis and physical and chemical properties of methyl derivatives of Eudragit S. Int. J. Pharm 1993; 94: 125–134
   Web of Science ®Google Scholar
• Phillips S. F. Gastrointestinal physiology and its relevance to targeted drug delivery. Current Status on Targeted Drug Delivery to the Gastrointestinal Tract. Capsugel Symposia Series, 1993; 8–18
   Google Scholar
• Pozzi F., Furlani P., Gazzaniga A., Davis S. S., Wilding I. R. The TIME-CLOCK® system: a new oral dosage form for fast and complete release of drug after a predetermined lag time. J. Controlled Rel 1994; 31: 99–108
   Web of Science ®Google Scholar
• Rahman A., Barrowman J. A., Rahimtula A. The influence of bile on the bioavailability of polynuclear aromatic hydrocarbons from rat intestines. Can. J. Physiol. Pharmacol 1986; 64: 1214–1218
   PubMed Web of Science ®Google Scholar
• Rihova B., Rathi R. C., Kopeckova P., Kopecek J. In vitro bioadhesion of carbohydrate-containing N-(2-hydro-xypropyl)methacrylamide copolymers to the GI tract of guinea pigs. Int. J. Pharm 1992; 87: 105–116
   Google Scholar
• Roslyn J. J., Zinner M. Y. Surgical anatomy and operative procedures. Textbook of Surgery, D. L. Sabiston. W. B. Saunders Co., Philadelphia 1991; 899–901
   Google Scholar
• Rowland I. R. Factors affecting metabolic activity of the intestinal microflora. Drug Metabol. Rev 1988; 19: 243–261
   PubMed Web of Science ®Google Scholar
• Rubinstein A. Microbially controlled drug delivery to the colon. Biopharm. Drug Dispos 1990; 11: 465–475
   PubMed Web of Science ®Google Scholar
• Rubinstein A., Gliko-Kabir I. Synthesis and swelling-dependent enzymatic degradation of borax-modified guar gum for colonic delivery purposes. S. T. P. Pharma Sci 1995; 5: 41–46
   Web of Science ®Google Scholar
• Rubinstein A., Nakar D., Sintov A. Colonic drug delivery enhanced release of indomethacin from cross-linked chondroitin matrix in rat caecal contents. Pharm. Res 1992a; 9: 276–278
   PubMed Web of Science ®Google Scholar
• Rubinstein A., Nakar D., Sintov A. Chondroitin sulfate: a potential biodegradable carrier for colon-specific drug delivery. Int. J. Pharm 1992b; 84: 141–150
   Web of Science ®Google Scholar
• Rubinstein A., Radai R., Ezna M., Pathnack S. In vitro evaluation of calcium pectate: A potential colon-specific drug delivery carrier. Pharm. Res 1993; 10: 258–263
   PubMed Web of Science ®Google Scholar
• Rubinstein A., Radai R. In vitro and in vivo analysis of colon specificity of calcium pectinate formulations. Eur. J. Pharm. Biopharm 1995; 41: 291–295
   Web of Science ®Google Scholar
• Saffran M., Kumar G. S., Savariar C., Burnham J. C., Williams S., Neckers D. C. A new approach to the oral administration of insulin and other peptide drugs. Science 1986; 233: 1081–1084
   PubMed Web of Science ®Google Scholar
• Saffran M., Kumar G. S., Neckers D. G., Williams F., Field J. B., Jones R. H., Panepinto L. New approaches to the oral administration of peptide drugs. Pharm. Week Sci. Ed 1988; 10: 43–44
   Google Scholar
• Saffran M., Field J. B., Pena J., Jones R. H., Okuda Y. Oral insulin in diabetic dogs. J. Endocrinol 1991; 131: 267–278
   PubMed Web of Science ®Google Scholar
• Sakai K., Kutsuna T. M., Nishino T., Fujihara Y., Yata N. Contribution of calcium ion sequestration by polyoxyethylated nonionic surfactants to the enhanced colonic absorption of p-aminobenzoic acid. J. Pharm. Sci 1986; 75: 387–390
   PubMed Web of Science ®Google Scholar
• Samuel P. G., Sypol G. M., Meilman E., Mosbach E. H., Chafizadeh M. Absorption of bile acids from large bowel in man. J. Clin. Invest 1968; 42: 2070–2078
   Google Scholar
• Samyn C., Kalala W., Van den Mooter G., Kinget R. Synthesis and in vitro biodegradation of poly(ether-ester) azo polymers designed for colon targeting. Int. J. Pharm 1995; 121: 211–216
   Google Scholar
• Sarlikiotis A. W., Bauer K. H. Synthese und unterschung von polyurethanen mit galactomannan-segmenten als hilfsstoffe zur freizetzung von peptid-arzneistoffen im dickdarm. Pharm. Ind 1992; 54: 873–886
   Google Scholar
• Schacht E., Gevaert A., Kenawy E. R., Molly K., Verstraete W., Adriaensens P., Carleer R., Gelan R. Polymers for colon specific drug delivery. J. Controlled Rel 1996; 39: 327–338
   Web of Science ®Google Scholar
• Scheline R. R. Metabolism of foreign compounds by gastrointestinal microorganisms. Pharmacol. Rev 1973; 25: 451–523
   PubMed Web of Science ®Google Scholar
• Shanta K. L., Ravishandran P., Rao K. P. Azo polymeric hydrogels for colon targeted drug delivery. Biomaterials 1995; 16: 1313–1318
   PubMed Web of Science ®Google Scholar
• Simon G. L., Gorbach S. L. The human intestinal microflora. Dig. Dis. Sc 1986; 31: 147S–162S
   PubMed Web of Science ®Google Scholar
• Simonsen L., Hovgaard L., Mortensen P. B., Brondsted H. Dextran hydrogels for colon-specific drug delivery. V. Degradation in human intestinal incubation models. Eur. J. Pharm. Sci 1995; 3: 329–337
   Web of Science ®Google Scholar
• Spitael J., Kinget R. Solubilité et vitesse de dissolution de différents polymères entériques. Lab. Pharm 1977a; 25: 847–849
   Google Scholar
• Spitael J., Kinget R. Factors affecting the dissolution rate of enteric coatings. Pharm. Ind 1977b; 39: 502–505
   Google Scholar
• Spitael J., Kinget R. Solubility and dissolution rate of enteric polymers. Acta Pharm. Technol 1979; 25(Suppl 7)163–168
   Google Scholar
• Spitael J., Kinget R., Naessens K. Dissolution rate of cellulose acetate pthalate and the Bronsted catalysis law. Pharm. Ind 1980; 42: 846–849
   Google Scholar
• Stella V. Pro-drugs: an overview and definition. Pro-drugs as Novel Drug Delivery Systems, T. Higuchi, V. Stella. ACS, Washington, D. C 1975; 1–115
   Google Scholar
• Taniguchi K., Muranishi S., Sezaki H. Enhanced intestinal permeability to macromolecules. II. Improvement of the large intestinal absorption of heparin by lipid-surfactant mixed micelles in rat. Int. J. Pharm 1980; 4: 219–228
   Web of Science ®Google Scholar
• Thomas P., Richard A., Rogers L., Evans B. K., Dew M. J., Rhodes J. Absorption of delayed-release prednisolone in ulcerative colitis and Crohn's disease. J. Pharm. Pharmacol 1985; 37: 757–758
   PubMed Web of Science ®Google Scholar
• Tomita M., Shiga M., Hayashi M., Awazu S. Enhancement of colonic drug absorption by paracellular permeation route. Pharm. Res 1988; 5: 431–435
   Web of Science ®Google Scholar
• Touitou E., Rubinstein A. Targeted enteral delivery of insulin to rats. Int. J. Pharm 1986; 30: 95–99
   Web of Science ®Google Scholar
• Ueda S., Ibuki R., Kawamuza A., Murata S., Takahashi T., Kimuza S., Hata T. Development of a novel drug delivery system, Time-Controlled-Explosion System (TES). J. Drug Targeting 1994; 2: 133–140
   PubMed Web of Science ®Google Scholar
• Ueda T., Yamaoka T., Miyamoto M., Kimura Y., Sasatani H., Kim S. I. Bacterial reduction of azo compounds as a model reaction for the degradation of azo-containing polyurethane by the action of intestinal flora. Bull. Chem. Soc. Jpn 1996; 69: 1139–1142
   Web of Science ®Google Scholar
• Vandelli M. A., Leo E., Forni F., Bernabei M. T. In vitro evaluation of a potential colonic delivery system that releases drug after a controllable lag-time. Eur. J. Pharm. Biopharm 1996; 43: 148–151
   Google Scholar
• Van den Mooter G., Offringa M., Kalala W., Samyn C., Kinget R. Synthesis and evaluation of new linear azo-polymers for colonic targeting. S. T. P. Pharma Sci 1995; 5: 36–40
   Web of Science ®Google Scholar
• Van den Mooter G., Samyn C., Kinget R. Azo polymers for colon-specific drug delivery. Int. J. Pharm 1992; 87: 37–46
   Web of Science ®Google Scholar
• Van den Mooter G., Samyn C., Kinget R. Azo polymers for colon-specific drug delivery. Part II: Influence of the type of azo polymer on the degradation by intestinal microflora. Int. J. Pharm 1993; 97: 133–139
   Web of Science ®Google Scholar
• Van den Mooter G., Samyn C., Kinget R. The relationship between swelling properties and enzymatic degradation of azo polymers designed for colon-specific drug delivery. Pharm. Res 1994; 11: 1737–1741
   PubMed Web of Science ®Google Scholar
• Van den Mooter G., Samyn C., Kinget R. In vivo evaluation of a colon-specific drug delivery system: An absorption study of theophylline from capsules coated with azo polymers in rats. Pharm. Res 1995; 12: 244–247
   PubMed Web of Science ®Google Scholar
• Van Hozegard R. A. Pharmacokinetics of olsalazine and its metabolites. Scand. J. Gastroenterol 1988; 148(23 Suppl.)17–20
   Google Scholar
• Vervoort L., Kinget R. In vitro degradation by colonic bacteria of inulin HP incorporated in Eudragit films. Int. J. Pharm 1996; 129: 185–190
   Web of Science ®Google Scholar
• Wakerly Z., Fell J. T., Attwood D., Parkins D. Pectin/ethylcellulose film coating formulations for colonic drug delivery. Pharm. Res 1996; 13: 1210–1212
   PubMed Web of Science ®Google Scholar
• Wilding I. R., Davis S. S., Stevens H. N. E., Bakhshaee M., Sparrow R. A., Brennan J. Gastrointestinal transit and systemic absorption of captopril from a pulsed release formulation. Pharm. Res 1992; 9: 654–657
   PubMed Web of Science ®Google Scholar
• Willoughby C. P., Cowan R. E., Gould S. R., Machell R. J., Stewart J. B. Double-blind comparison of olsalazine and sulphasalazine in active ulcerative colitis. Scand. J. Gastroenterol 1988; 23(Suppl. 148)40–44
   Google Scholar
• Wilson C. G., Washington N. Physiological Pharmaceutics, Biological Barriers to Drug Absorption. Ellis Hor-wood Ltd., ChichesterUK 1989
   Google Scholar
• Wood E., Wilson C. G., Hardy J. G. The spreading of foam and solution enemas. Int. J. Pharm 1985; 25: 191–197
   Web of Science ®Google Scholar
• Yeh P. Y., Kopeckova P., Kopecek J. Biodegradable and pH-sensitive hydrogels: synthesis by crosslinking of N,N-dimethylacrylamide copolymer precursors. J. Polymer Sci. Part A Polymer Chem 1994; 32: 1627–1637
   Web of Science ®Google Scholar
• Yeh P. Y., Berenson M. M., Samowitz W. S., Kopeckova P., Kopecek J. Site-specific drug delivery and penetration enhancement in the gastrointestinal tract. J. Controlled Rel 1995; 36: 109–124
   Web of Science ®Google Scholar
• Zeitoun P., Brisard P. Im colon zelfallende tabletten und ihre herstellung, Patent Rousel-Uclaf, Patentschrift DE. 3046559 C2, 1988
   Google Scholar